JAC Advance Access originally published online on October 24, 2006
Journal of Antimicrobial Chemotherapy 2007 59(1):157; doi:10.1093/jac/dkl437
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
Correspondence |
Comment on: Quinolone resistance determinant qnrA3 in clinical isolates of Salmonella in 20002005 in Hong Kong
1 Staphylococcal Reference Unit, Laboratory of Health-Care Associated Infection Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK 2 Antibiotic Resistance Monitoring and Reference Laboratory Centre for Infections, Health Protection Agency, 61 Colindale Avenue, London NW9 5EQ, UK
*Corresponding author. Tel: +44-20-8327-7259; Fax: +44-20-8200-7449; E-mail: matthew.ellington@hpa.org.uk
Keywords: plasmidic resistance , toxinantitoxin , plasmid addiction
| The first 10% of the full text of this article appears below. |
Sir,
In their recent correspondence, Chu et al.1 noted the first observation of qnrA3 in salmonellae in Hong Kong,1 underlining the spread and diversity of plasmidic quinolone-resistance determinants worldwide. Such determinants now include qnrA15,
Transparency declarations